Issued Patents All Time
Showing 25 most recent of 43 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10725051 | Multiplex MRM assay for evaluation of cancer | David B. Krizman, Sheeno Thyparambil, Wei-Li Liao | 2020-07-28 |
| 10722509 | Predicting optimal chemotherapy for CRC | Fabiola CECCHI | 2020-07-28 |
| 10722531 | OPRT expression and cancer treatment outcome | Fabiola CECCHI, Dongyao YAN | 2020-07-28 |
| 10725045 | Quantifying MGMT protein for optimal cancer therapy of glioblastoma | Fabiola CECCHI, Dongyao YAN | 2020-07-28 |
| 10718780 | SRM/MRM assay for the tyrosine-protein kinase receptor UFO(AXL) protein | David B. Krizman, Adele Blackler, Wei-Li Liao | 2020-07-21 |
| 10620223 | SRM/MRM assay for the fibroblast growth factor receptor 2 (FGFR2) protein | David B. Krizman, Sheeno Thyparambil, Wei-Li Liao | 2020-04-14 |
| 10617717 | Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy | Fabiola CECCHI, Jean-Charles Soria | 2020-04-14 |
| 10620184 | SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein | David B. Krizman, Eunkyung An | 2020-04-14 |
| 10585099 | SRM/MRM assays for cancer | Fabiola CECCHI, Sarit SCHWARTZ, Kerry SCOTT | 2020-03-10 |
| 10537576 | Methods for treating Her2-positive breast cancer | Adele Blackler, Fabiola CECCHI, Paolo Nuciforo | 2020-01-21 |
| 10302656 | CMET protein SRM/MRM assay | David B. Krizman, Sheeno Thyparambil | 2019-05-28 |
| 10288616 | Quantifying met protein for cancer treatment | Daniel CATENACCI, Fabiola CECCHI, Wei-Li Liao | 2019-05-14 |
| 10215761 | Bcl-2-like protein 11 SRM/MRM assay | David B. Krizman, Sheeno Thyparambil, Wei-Li Liao | 2019-02-26 |
| 10208130 | Quantifying Her2 protein for optimal cancer therapy | Yung-Jue Bang, Eunkyung An, Do-Youn Oh | 2019-02-19 |
| 10202635 | SRM/MRM assay for the ephrin type-A receptor 2 protein | David B. Krizman, Wei-Li Liao, Sheeno Thyparambil | 2019-02-12 |
| 10203336 | SRM/MRM assay for the tyrosine-protein kinase receptor UFO (AXL) protein | David B. Krizman, Adele Blackler, Wei-Li Liao | 2019-02-12 |
| 10126307 | SRM/MRM assay for the androgen receptor (AR) protein | David B. Krizman, Sheeno Thyparambil, Eunkyung An | 2018-11-13 |
| 10101334 | Multiplex MRM assay for evaluation of cancer | David B. Krizman, Sheeno Thyparambil, Wei-Li Liao | 2018-10-16 |
| 10078084 | SRM/MRM assay for the mesothelin (MSLN) protein | David B. Krizman, Eunkyung An, Sheeno Thyparambil | 2018-09-18 |
| 10073075 | SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein | David B. Krizman, Eunkyung An | 2018-09-11 |
| 10060927 | SRM/MRM assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) protein | David B. Krizman, Eunkyung An, Sheeno Thyparambil, Wei-Li Lao | 2018-08-28 |
| 10054592 | Insulin receptor substrate 1 (IRS1) protein SRM/MRM assay | David B. Krizman, Sheeno Thyparambil | 2018-08-21 |
| 10041961 | SRM/MRM assay for the insulin receptor protein | David B. Krizman, Wei-Li Liao, Sheeno Thyparambil | 2018-08-07 |
| 9869680 | HER3 protein SRM/MRM assay | David B. Krizman, Sheeno Thyparambil | 2018-01-16 |
| 9840728 | SRM assay to indicate cancer therapy | David B. Krizman, Sheeno Thyparambil, Wei-Li Liao | 2017-12-12 |